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Abstract Calcineurin (CAN) is a calcium- and calmodulin- 
dependent serinelthreonine phosphatase whose inhibition by the 
immunosuppressant-immunophilin complexes (cyclosporin-cyclo- 
philin and FK506-FKBP) is considered key to the mechanism of 
immunosuppression. CaN is a heterodimer, consisting of a 59 
kDa catalytic subunit (A) and a 19 kDa calcium-binding regula- 
tory subunit (B). The latter is postulated to harbor four calcium 
binding domains of the EF hand type. The titration of the CaN 
B apoprotein with the isomorphic Cd 2÷ was followed by H3Cd 
NMR and these data support one high-affinity metal binding site 
and three lower-affinity ones. Flow dialysis data with Ca 2+ indi- 
cate one high affinity calcium binding site with K d ~2.4 × I0 -s M 
and three other sites with Kd -1.5 × 10 -5 M. The chemical shifts 
of all four H3Cd resonances (-75, -93, -106 and - I  19 ppm) are 
in the same range as found in other H3Cd substituted calcium- 
binding proteins, and are indicative of all-oxygen coordination of 
pentagonal bipyramidal geometry. 
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1. Introduction 
Calcineurin (CAN), also known as protein phosphatase 2B, 
is a Ca 2+- and calmodulin (CaM)-dependent serine/threonine 
phosphatase consisting of a 59 kDa catalytic subunit (A) and 
a 19 kDa regulatory subunit (B) that binds Ca 2+ [1]. CaN is 
inhibited by the immunosuppressant- immunophil in complexes 
of cyclosporin (CsA)-cyclophilin (CyP) and FK506-FKBP [2]. 
Apparently, CaN inhibition blocks the translocation and as- 
sembly of the nuclear transcription factor of activated T cells 
(NF-AT), thus preventing the transcription of cytokine genes 
and T cell activation [3]. CaNB is essential for the CaN phos- 
phatase activity [1], and for the binding of immunosuppressant- 
immunophil in complexes to CaN [4]. The regulation of the CaN 
phosphatase activity by intracellular Ca 2+ is mediated by the 
calcium-binding proteins CaNB and CaM which interact with 
CaNA at distinct sites in a tight trimeric complex [1]. On the 
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basis of its amino acid sequence, CaNB is postulated to harbor 
four calcium-binding sites of the EF hand type [5], similar to 
the helix-loop-helix motif of other calcium-binding proteins 
such as troponin C (TnC) and CaM [6]. Metal-binding sites of 
Cd2+-substituted metalloproteins can be probed by H3Cd 
NMR, thus taking advantage of the favorable characteristics 
of this spin-l/2 nucleus [7-9]. This metal ion substitution is
especially homologous for calcium-binding proteins since the 
0.99 A-radius Ca 2+ is isomorphically replaced by the 0.97 A- 
radius Cd 2+ ion. We have thus undertaken a ll3Cd NMR inves- 
tigation of CaNB, in conjunction with calcium flow dialysis 
experiments o quantitate the metal binding affinities and asso- 
ciate them with the specific metal binding sites. 
2. Materials and methods 
2.1. Preparation and purification of recombinant CaNB (rCaNB) 
Myristoylated rCaNB was expressed and isolated from the E. coli 
strain BL21(DE3) [10] containing the plasmids pBBI31 [11] and 
pRCNBT775 3 [12]. The plasmid pBBI31, kindly provided by Dr. 
Jeffrey Gordon, Washington University, St. Louis, MO, contains the 
gene for Saccharomyces cerevisiae myristoyl-coenzyme A:protein N- 
myristoyltransferase (E.C. 2.3.1.97) under control of the tac promoter 
while pRCNB775 3 contains the gene for rat calcineurin B (Genbank 
accession umber L03554) under control of the T7 promoter. The 
protein was purified from cells grown in 15 liter of LB broth using anion 
exchange and gel filtration chromatographies as described [12]. The 
protein appeared homogeneous as judged from Coomassie blue-stained 
13% sodium dodecylsulfate polyacrylamide g ls. 
2.2. NMR sample preparation and protein-Cd titration 
Since purified rCaNB has a tendency to readily oligomerize via thiol 
oxidation and crosslinking, the two free cysteine residues of the recom- 
binant protein were carboxymethylated. Theprotein was first concen- 
trated to 6.5 mg/ml using an Amicon stirred cell equipped with a Diaflo 
YM3 membrane (Amicon, Beverly, MA) followed by the addition of 
two equivalents offl-mercaptoethanol (final concentration, 670 pM). 
After a 30 min incubation at 30°C, iodoacetic acid was added to 
65 raM, the pH of the sample raised to approximately 8 with solid Tris, 
and the sample incubated for an additional 30 min at room tempera- 
ture. The reaction was then quenched by incubating the sample for 30 
min at room temperature after adding fl-mercaptoethanol to 130 mM. 
Carboxymethylated CaNB was fully functional toward potentiating the 
phosphatase activity of CaNA (data not shown). The protein was first 
dialyzed overnight against 1.0 liter of 25 mM HEPES, pH 7.0 buffer 
with Chelex-100 resin (Bio-Rad, Hercules, CA), and then overnight 
against water at 4°C. It was then concentrated under N 2 by ultrafiltra- 
tion to -2 ml using an Amicon Microconcentrator equipped with a 
YM-10 membrane at4°C and buffer-exchanged against 5ml of 0.02% 
NaN 3 in 90% H20/10% D20, pH 6.2 (henceforth referred to as the 
solvent). The apo-rCaNB was reconstituted bysuccessive additions of 
aliquots from a H3CdC12 (96.3 atom% t~3Cd) stock solution prepared 
by dissolving ~3CdO (Oakridge National Laboratory) in conc. HCI, 
evaporating the solvent, and taking up the salt in water. In order to 
avoid possible interactions ofCd z+ with buffer components that could 
affect t~ 3Cd chemical shifts and linewidths, no buffer was used. During 
the titration, the requisite quantity of ~3CdCI~ in 5 ml solvent was 
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gradually added to the protein via the exchange compartment of the 
Amicon Microconcentrator. The final NMR samples consisted of ca. 
2.0 to 2.2 ml of 0.9 1.0 mM rCaNB. Protein concentrations were 
determined with the Bio-Rad protein assay using BSA as a standard 
[13]. The Cd content of the 113CdC12 stock solution, the protein samples 
and the Amicon filtrates was measured by atomic absorption, using a 
Perkin Elmer 3030 spectrophotometer. 
2.3. NMR measurements 
Proton (500.13 MHz) and cadmium-113 (110.92 M Hz) NMR spectra 
were acquired on a Bruker AM500 NMR spectrometer at 5, 25 or 35 ° C, 
using a 5 mm proton-selective or a 10 mm broadband probe, respec- 
tively. For the proton-undecoupled IL3Cd NMR spectra, approximately 
34K transients were recorded with 8K complex points over a 20 kHz 
spectral width, using a 55 ° nutation angle and a 2 s interpulse delay. 
Spectra were processed on a Silicon Graphics Indigo workstation using 
the FELIX software package (Biosym Technologies, San Diego, CA). 
The 113Cd NMR spectra were referenced to external 0.l M Cd(ClO4) 2 
in 90% H_,O/10% D20 (0.00 ppm). 
2.4. Flow dialysis experiments 
Myristoylated rCaNB for flow dialysis experiments was made Ca 2+- 
free by exhaustive dialysis against flow dialysis buffer (20 mM HEPES, 
0.2 M KC1, 1 mM DTT, pH 7.5) with Chelex-100 resin (Bio-Rad, 
Hercules, CA) outside the dialysis bag. Glassware and plasticware used 
in the Ca2+-binding experiments were acid-washed prior to use in order 
to minimize contaminating metals. Distilled water for washing and 
buffer preparation was tested for calcium prior to use and found to be 
calcium free by atomic absorption spectrophotometry. Dialysis tubing 
was boiled in 10 mM EDTA followed by extensive washing with dis- 
tilled water. A portion of the dialyzed apoprotein, tested for the pres- 
ence of calcium using atomic absorption spectrophotometry, had < 0.03 
mol Ca 2+ bound/mol CaNB. 
Flow dialysis was carried out as described [14] using a modified flow 
dialysis unit purchased from Spectrum Technologies. Briefly, the upper 
buffer chamber contained 5/IM CaZ+-free CaNB and 5/~M 45CAC12 in 
a total volume of 2.2 ml Ca2÷-free flow dialysis buffer. The upper and 
lower buffer chambers were separated by a 12 14 kDa cut-off dialysis 
membrane. The flow rate of flow dialysis buffer through the lower 
chamber was 6 ml/min, with the effluent diverted to a fraction collector. 
II I ~ IV 
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Fig. 1. Cadmium-113 NMR spectra (110.9 MHz) of I mM recombinant 
rat CaNB titrated with mCdClz at the indicated metal-to-protein molar 
ratios. The spectra were recorded in unbuffered aqueous olutions at 
pH 6.3, 25°C and referenced vs. external 0.1 M Cd(C104)2. The inverted 
downfield resonance of spectrum D is attributed to the free-bound, 
exchange-averaged H3Cd signal that cannot be properly phased because 
of aliasing. 
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Fig. 2. Temperature dependence of the l l3Cd NMR of I mM CaNB in 
the presence of 3.6 equivalents of H3Cd2+. 
The entire experiment lasted approximately 1.5 h. Only 5-8% of the 
45Ca2+ initially present in the upper chamber was depleted in the exper- 
iment, an amount not expected to affect binding parameters apprecia- 
bly [27]. 
In order to obtain an estimate of the dissociation constants for Ca 2÷ 
binding to CaNB and the number of each binding site, data from flow 
dialysis experiments were fit by a least squares procedure to the equa- 
tion [15 17]: 
9= Y n Ki[Ca2+]/(1 + KI[Ca2+]) (1) 
where 9is the number of moles of Ca 2+ per mol of CaNB, n~ refers to 
the number of binding sites with binding constant K~, and [Ca 2+] refers 
to the free Ca 2+ concentration. 
3. Results 
The successive addition of 113CdC12 aliquots to apo-CaNB 
gave rise to four 113Cd NMR resonances at -75, -93, -106, and 
-119 ppm (resonances I IV, respectively, Fig. 1). Further addi- 
tion of metal, resulted in the eventual replacement of these 
resonances by a single broad, exchange-averaged, downfield 
J~3Cd resonance at ca. +60 ppm. Lowering the temperature 
from 25°C to 5°C, at the level of 3.6 equivalents of added Cd 2+, 
caused a measurable narrowing of the two most downfield 
resonances, presumably because of the slowing of dynamic 
processes that modulate these Z l3Cd2+ signals (Fig. 2). The in- 
tensity/area variation of the ll3Cd resonances as a function of 
added t t3Cd2+ (Fig. 3), indicates that the most downfield reso- 
nance ( -75 ppm) corresponds to a strong binding site that is 
saturated at a 2:1 metal-to-protein molar ratio whereas the 
other three resonances arise from weaker metal binding sites 
that are only partially occupied at the metal-to-protein ratios 
examined. 
The binding of Ca 2+ to CnB measured by flow dialysis 
showed a biphasic nature indicative of high and lower affinity 
sites (Fig. 4). For [Ca 2+] ~ 3/~M, a single binding site is evident 
while for higher [Ca2+], three additional sites become popu- 
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lated. A least squares fit of the Ca 2+ binding data using a model 
for non-interacting sites gave one binding site (n = 1.2) with 
Kd = 0.024/.tM and three sites (n = 2.5) with Kd = 15tiM (solid 
curve, Fig. 4). Data at [Ca2+~ee] high enough to demonstrate 
saturation could not be obtained since the difference between 
[Ca2+fr~e] and [Ca2+total] was  comparable to the error associated 
with measuring their values, a practical limitation of the flow 
dialysis method. A Hill plot for [Ca 2+] > 10 pM gave a Hill 
coefficient of 1.4, indicating that only slight cooperativity exists 
between the three lower affinity sites. 
4. Discussion 
The well-documented sensitivity of 113Cd NMR chemical 
shifts to the identity and number of the metal ligands [7--9] 
allows the clear resolution of all four CaNB metal binding sites 
by 113Cd NMR. The observed chemical shifts, being in the same 
range as those of other calcium-binding proteins, are suggestive 
of all-oxygen metal igation of similar pentagonal bipyramidal 
geometry [7 9]. Generally, Cd 2+ is an excellent structural probe 
for the EF hand calcium binding sites [18]; the reported excep- 
tions of intestinal calcium-binding protein [19] and calbindin 
9K [20] concern atypical EF hands. Similarly to CaM and TnC, 
two other calcium-binding proteins that are structurally related 
to CaNB, the relative intensity increase of the u3Cd NMR 
resonances during a titration experiment [21,22] should reflect 
the relative affinities of the protein's metal binding sites [15,23]. 
On visual inspection, the tl3Cd NMR titration data (Fig. 1) 
seems to indicate three strong metal binding sites that corre- 
spond to resonances I, II and IV which develop immediately, 
and a weaker binding site (resonance III). This analysis does 
not, however, take into account possible differences in the 1~3Cd 
NMR resonance relaxation times [24]. More thorough quantifi- 
cation of the lt3Cd NMR titration data (Fig. 3) suggests that 
the metal binding site corresponding to resonance I is stronger 
than the other three. Unfortunately, exchange averaging of 
L i3Cd resonances probihits extending the titration much beyond 
3.6 equivalents of Cd 2÷. 
Inspection of the rat CaNB sequence reveals the 12-residue 
sequences that comprise the Ca 2+ binding loops of the four 
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Fig. 3. Peak intensity/area increase in H3Cd signals at -75 ppm (e), -93 
ppm (m), -106ppm (,), and -119 ppm (A) upon titration of 1 mM 
CaNB with t~3CdCl2. 
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Fig. 4. A plot ofmol Ca 2+ bound/mol CaNB as a function of free Ca 2+ 
concentration. The squares represent data points from two separate 
flow dialysis experiments. The line represents a least-squares fit to the 
data using Eq. 1, as detailed in the results ection. 
helix-loop-helix EF-hands (Table 1) which, being highly homol- 
ogous to those of other calcium-binding proteins, should bind 
calcium via seven oxygen atoms in a pentagonal bipyramidal 
geometry [25]. However, the observed large variation in the 
calcium affinity (K d = 10-5-10-8M) of the CaNB binding sites 
may not simply reflect he individual binding loop amino acid 
sequences but also those of the adjacent helices and, given that 
EF-hand pairs rather than single EF-hands are the functional 
units of calcium-binding proteins, the other EF-hand of the pair 
as well [26]. 
The presence of a single strong and three weak Ca 2+ binding 
sites of isolated CaNB (this study) is in contrast with the two 
strong (K~ < 70 nM) and two weak Ca 2÷ binding sites of prote- 
olyzed CaN [27], perhaps suggesting that the CaNA-CaNB 
interaction can also influence the affinity of metal binding sites 
on CaNB. In fact, using isolated unmyristoylated CaNB, Bur- 
roughs et al. measured by luminescence spectroscopy four dis- 
sociation constants for Eu 3÷ binding with values of 20 nM, 140 
nM, 1.0/~M and 1.6 pM [28]. Flow dialysis of a preparation of 
unmyristoylated calcineurin B yielded a Ca2+-binding curve 
identical to the one obtained here (data not shown), indicating 
that myristoylation does not affect metal affinity, a result found 
for another EF hand protein, recoverin [29]. Although part of 
the difference in K d values between EH 3+ versus  Ca 2+ binding 
to CaNB can be attributed to the different valencies of the 
associated metal, other conditions uch as ionic strength, pH 
and [Mg 2+] which differ in these two studies, can affect binding 
interactions in the EF-hand family with metal protein affinities 
varying by more than an order of magnitude under different 
buffer conditions [30]. 
Cooperative metal binding is common among Ca2÷-binding 
proteins such as CaM and TnC, enabling them to promptly 
regulate their biological function in response to moderate 
changes in Ca 2+ concentration. Although ligand binding data 
with isolated CaNB revealed two types of non-interacting sites 
with high and lower Ca 2+ affinities, slight (Hill coefficient -- 
1.4) cooperativity exists among the three low affinity sites. 
These data are in accord with a Hill coefficient of 1.8 for [Ca 2+] 
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Table 1 
Sequences of the calcium-binding loops in CaNB" 
Residues Positions 
1 2 3 4 5 6 7 8 9 l0 l l 12 
31-42 D L D N S G S L S V E E 
63 74 D T D G N G E V D F K E 
100 111 D M D K D G Y I S N G E 
141-152 D K D G D G R ! S F E E 
"Each metal should be coordinated [25] by a D1 carboxyl oxygen (+X), 
a D3 carboxyl oxygen (+Y), a residue 5side chain oxygen (+Z), a water 
oxygen (-X), the residue 7 backbone carbonyl oxygen (-Y) and both 
El2 carboxyl oxygens (-Z1, -Z2). 
> 10 ¢tM observed for the Ca2+-dependent activation of a pro- 
teolyzed, calmodulin-independent form ofcalcineurin [27]. The 
appearance of four U3Cd resonances corresponding to the four 
CaNB sites during ~j3Cd2+ titrations is not surprising since both 
[CaNB] and [Cd >] were millimolar or greater. With the Kd 
values measured by flow dialysis, all four metal sites should be 
appreciably occupied at [CdZ+]/[CaNB] ratios of 1.0 or greater. 
Both CaM and TnC are dumbbell-shaped molcules that con- 
sist of two similar globular domains, each harboring a pair of 
EF-hands, which are connected by a flexible helix [31,32]. It is 
most likely that the ongoing structure lucidation of CaNB [33] 
will reveal a similar protein fold. A comparison between the 
Ca2+-filled C-domain of TnC and its CaZ+-free N-domain 
showed a prominent hydrophobic surface that is accessible in 
the former but not the latter, thus implicating it in the Ca 2+- 
induced binding of target molecules [25]. Both apo-TnC and 
apo-CaM undergo conformational changes upon Cd 2+ binding 
that are very similar to those caused by Ca 2. and which are 
readily observed by 1H NMR [34,35]. This is also the case for 
the apo-CaNB studied (data not shown) although the spectral 
changes are obscured by the large linewidths of the protein that 
tends to aggregate in solution [36]. 
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